 40 patients will be recruited to receive PegLiposomal Doxorubicin PLD in a continuous i. v. infusion of at least 60 minutes at a dose of 40 mgm2 on Day 1, followed by a 30-minute i. v. carboplatin infusion according to AUC 6 formula devised by Calvert et al. 